breast cancer
MATERIAL AND METHODS: Twenty-one premenopausal women with advanced breast cancer        were randomised to receive the GnRH analog triptorelin (3.75 mg i.m.
MATERIAL AND METHODS: Twenty-one premenopausal  @OBJECT$   @PREDICAT$  advanced  @SUBJECT$         were randomised to receive the GnRH analog triptorelin (3.75 mg i.m.